FineMark National Bank & Trust’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-62
Closed -$2K 616
2016
Q4
$2K Hold
62
﹤0.01% 1162
2016
Q3
$1K Hold
62
﹤0.01% 1243
2016
Q2
$1K Hold
62
﹤0.01% 1286
2016
Q1
$1K Hold
62
﹤0.01% 1218
2015
Q4
$2K Buy
62
+33
+114% +$829 ﹤0.01% 1168
2015
Q3
$1K Hold
29
﹤0.01% 1390
2015
Q2
$1K Buy
+29
New +$734 ﹤0.01% 1336

Other funds holding GMED

FineMark National Bank & Trust's GMED Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Globus Medical (GMED) in Q1 2017, closing a stake of 62 shares — an estimated $2K sold.

FineMark National Bank & Trust first reported a position in GMED in Q2 2015 and held it in 7 quarters. The position peaked at $2K in Q4 2016. 243 funds tracked by Wall St. Rank hold GMED as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Globus Medical position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 62 Globus Medical shares in Q1 2017, an estimated $2K.
  • FineMark National Bank & Trust first reported a position in Globus Medical in Q2 2015 and held it in 7 quarters.
  • FineMark National Bank & Trust's Globus Medical position peaked at $2K in Q4 2016.
  • 243 funds tracked by Wall St. Rank held Globus Medical as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.